INSIGHTS #65 - Understanding the Value of AI in Healthcare
If there is one thing that the pandemic is bound to teach humanity, it is the will to go with the flow and not plan too ahead in life. That said, counterintuitively, it seems important to be prepared and planned when similar outbreaks arise in the future. A healthcare startup from Canada, BlueDot, in its report, shared that the outbreak was fast spreading in China even before the World Health Organisation (WHO) had reported it. The startup’s outbreak risk software helps mitigate the exposure to infectious diseases using Artificial Intelligence. It goes to show that healthcare organisations, governments and public health officials would have to rely on these AI-based systems in the future to prevent similar outbreaks from reoccurring. On this podcast, Murali Aravumdan, Founder and CEO of nference and Radhika Ananth, Vice President at Accel cover some of the important applications of AI in healthcare, and the sub-segments that are still untouched by AI but have huge potential for disruption. We also cover the apprehension of the medical communities to adopt to new technologies and the steps to overcome them. The focus areas within healthcare for Accel are AI in diagnostics, drug discovery, precision medicine and digital therapeutics, with some recent investments made in these categories.